Your browser doesn't support javascript.
loading
Observations and findings during the development of a subnormothermic/normothermic long-term ex vivo liver perfusion machine.
Schuler, Martin J; Becker, Dustin; Mueller, Matteo; Bautista Borrego, Lucia; Mancina, Leandro; Huwyler, Florian; Binz, Jonas; Hagedorn, Catherine; Schär, Beatrice; Gygax, Erich; Weisskopf, Miriam; Sousa Da Silva, Richard Xavier; Antunes Crisóstomo, João Miguel; Dutkowski, Philipp; Rudolf von Rohr, Philipp; Clavien, Pierre-Alain; Tibbitt, Mark W; Eshmuminov, Dilmurodjon; Hefti, Max.
Afiliação
  • Schuler MJ; Wyss Zurich - ETH Zurich/University of Zurich, Zurich, Switzerland.
  • Becker D; Wyss Zurich - ETH Zurich/University of Zurich, Zurich, Switzerland.
  • Mueller M; Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland.
  • Bautista Borrego L; Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland.
  • Mancina L; Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland.
  • Huwyler F; Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.
  • Binz J; Wyss Zurich - ETH Zurich/University of Zurich, Zurich, Switzerland.
  • Hagedorn C; Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland.
  • Schär B; Entwicklung biomedizinische Anwendungen, Securecell AG, Urdorf, Switzerland.
  • Gygax E; Forschung und Entwicklung, Fumedica AG, Muri, Switzerland.
  • Weisskopf M; Center of Surgical Research, University Hospital Zürich, University of Zürich, Zurich, Switzerland.
  • Sousa Da Silva RX; Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland.
  • Antunes Crisóstomo JM; Wyss Zurich - ETH Zurich/University of Zurich, Zurich, Switzerland.
  • Dutkowski P; Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland.
  • Rudolf von Rohr P; Transport Processes and Reactions Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.
  • Clavien PA; Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland.
  • Tibbitt MW; Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.
  • Eshmuminov D; Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland.
  • Hefti M; Wyss Zurich - ETH Zurich/University of Zurich, Zurich, Switzerland.
Artif Organs ; 47(2): 317-329, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36106378
ABSTRACT

BACKGROUND:

Ex situliver machine perfusion at subnormothermic/normothermic temperature isincreasingly applied in the field of transplantation to store and evaluateorgans on the machine prior transplantation. Currently, various perfusionconcepts are in clinical and preclinical applications. Over the last 6 years ina multidisciplinary team, a novel blood based perfusion technology wasdeveloped to keep a liver alive and metabolically active outside of the bodyfor at least one week.

METHODS:

Within thismanuscript, we present and compare three scenarios (Group 1, 2 and 3) we werefacing during our research and development (R&D) process, mainly linked tothe measurement of free hemoglobin and lactate in the blood based perfusate. Apartfrom their proven value in liver viability assessment (ex situ), these twoparameters are also helpful in R&D of a long-term liver perfusion machine and moreover supportive in the biomedical engineering process.

RESULTS:

Group 1 ("good" liver on the perfusion machine) represents the best liver clearance capacity for lactate and free hemoglobin wehave observed. In contrast to Group 2 ("poor" liver on the perfusion machine), that has shown the worst clearance capacity for free hemoglobin. Astonishingly,also for Group 2, lactate is cleared till the first day of perfusion andafterwards, rising lactate values are detected due to the poor quality of theliver. These two perfusate parametersclearly highlight the impact of the organ quality/viability on the perfusion process. Whereas Group 3 is a perfusion utilizing a blood loop only (without a liver).

CONCLUSION:

Knowing the feasible ranges (upper- and lower bound) and the courseover time of free hemoglobin and lactate is helpful to evaluate the quality ofthe organ perfusion itself and the maturity of the developed perfusion device. Freehemoglobin in the perfusate is linked to the rate of hemolysis that indicates how optimizing (gentle blood handling, minimizing hemolysis) the perfusion machine actually is. Generally, a reduced lactate clearancecapacity can be an indication for technical problems linked to the blood supplyof the liver and therefore helps to monitor the perfusion experiments.Moreover, the possibility is given to compare, evaluate and optimize developed liverperfusion systems based on the given ranges for these two parameters. Otherresearch groups can compare/quantify their perfusate (blood) parameters withthe ones in this manuscript. The presented data, findings and recommendations willfinally support other researchers in developing their own perfusion machine ormodifying commercially availableperfusion devices according to their needs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Hemólise Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Artif Organs Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Hemólise Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Artif Organs Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça